We provide the first demonstration that, in agreement with reports from prostate cancer models, modification of the HSCs population resulted in alteration of the overall number of ER-ve breast cancer cells detected in the bone microenvironment. This evidence concerns the gene ESR1 and Familial prostate cancer.